Two PrEP Meds Work Equally Well; One Is Much Cheaper
THURSDAY, Aug. 5, 2021 (HealthDay News) — The two HIV prevention drugs available in the United States are equally safe and effective, and the biggest difference between them is price, a new study contends. However, a sizable minority of patients have switched from the older and cheaper “preexposure prophylaxis” (PrEP)Continue Reading